CEO Steve Lydeamore To Present
Sydney, Nov 18, 2019 AEST (ABN Newswire) - Anatara Lifsciences Ltd (
ASX:ANR) CEO Steve Lydeamore has been invited to present at the Pitt Street Research Life Sciences Conference on the 28th November in Sydney. Any investors interested in attending these presentations are invited to reach out.
Details and registration links are summarised below:
Pitt Street Research Life Sciences Conference
This is a unique opportunity to meet some of the leading ASX-listed Biotechnology companies that focus on AgBiotech and Veterinary Biotech, with keynote speaker, Rick Holliday-Smith, Chairman of the Australian Securities Exchange (ASX:ASX), Cochlear (ASX:COH) and QBiotics, as well as Director of Servcorp (ASX:SRV).
Steve will provide an update on Anatara's work in gastrointestinal health for both humans and animals.
- Thursday 28th November 2019
- 8.45am until 1pm AEDST
- Baker McKenzie, Tower One - International Towers Sydney, Level 46, 100 Barangaroo Avenue, Sydney
Register to attend: contact Hayley van der Meer at hvandermeer@anatara.com.
About Anatara Lifesciences Limited
Anatara Lifesciences Limited (ASX:ANR) is developing and commercialising innovative, evidence-based products for gastrointestinal health where there is significant unmet need. Anatara is a life sciences company with expertise in developing productsfor human and animal health. Anatara is focused on building a pipeline of human gastrointestinal health products. Underlying this product development program is our commitment to delivering real outcomes for patients and strong value for our shareholders.
| ||
|
